We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$71.7B
AUM Growth
+$2.34B
Cap. Flow
+$1.49B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.97%
Holding
3,809
New
183
Increased
1,708
Reduced
1,572
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 10.59%
2 Financials 9.51%
3 Healthcare 8.04%
4 Industrials 6.62%
5 Communication Services 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWP
2351
abrdn Global Premier Properties Fund
AWP
$358M
$746K ﹤0.01%
39,989
+439
+1% +$8.11K
QDEL icon
2352
QuidelOrtho
QDEL
$959M
$744K ﹤0.01%
12,130
-4,974
-29% -$299K
EHT
2353
DELISTED
Eaton Vance 2021 Target Term Trust
EHT
$744K ﹤0.01%
74,590
-11,120
-13% -$110K
CHN
2354
DELISTED
China Fund
CHN
$743K ﹤0.01%
38,294
-4,400
-10% -$87.4K
NWBI icon
2355
Northwest Bancshares
NWBI
$2.29B
$742K ﹤0.01%
45,265
+1,450
+3% +$24.2K
JOYY
2356
JOYY Inc
JOYY
$3.7B
$742K ﹤0.01%
13,203
-9,305
-41% -$565K
BICK
2357
DELISTED
First Trust BICK Index Fund
BICK
$742K ﹤0.01%
29,257
+855
+3% +$22.2K
MORN icon
2358
Morningstar
MORN
$7.33B
$740K ﹤0.01%
5,067
-139
-3% -$21.4K
CGC
2359
Canopy Growth
CGC
$422M
$739K ﹤0.01%
3,226
+785
+32% +$240K
BBDC icon
2360
Barings BDC
BBDC
$975M
$738K ﹤0.01%
72,679
+1,749
+2% +$17.4K
TEX icon
2361
Terex
TEX
$7.74B
$738K ﹤0.01%
28,413
-4,479
-14% -$123K
IBKC
2362
DELISTED
IBERIABANK Corp
IBKC
$735K ﹤0.01%
9,736
-382
-4% -$28.2K
FHLC icon
2363
Fidelity MSCI Health Care Index ETF
FHLC
$3.41B
$734K ﹤0.01%
+16,931
New +$750K
CBT icon
2364
Cabot Corp
CBT
$4.49B
$731K ﹤0.01%
16,131
+2,952
+22% +$127K
IOSP icon
2365
Innospec
IOSP
$2.31B
$728K ﹤0.01%
+8,163
New +$732K
KRG icon
2366
Kite Realty
KRG
$5.24B
$728K ﹤0.01%
45,070
-585
-1% -$8.96K
MEN
2367
DELISTED
Blackrock Muni Enhanced Fund, Inc.
MEN
$728K ﹤0.01%
64,237
-8,619
-12% -$97.5K
SMB icon
2368
VanEck Short Muni ETF
SMB
$314M
$725K ﹤0.01%
40,978
+30,910
+307% +$549K
BME icon
2369
BlackRock Health Sciences Trust
BME
$577M
$724K ﹤0.01%
18,927
+704
+4% +$27.1K
NXTG icon
2370
First Trust Indxx NextG ETF
NXTG
$562M
$724K ﹤0.01%
14,392
+8,724
+154% +$435K
ACP
2371
abrdn Income Credit Strategies Fund
ACP
$641M
$723K ﹤0.01%
59,928
-4,477
-7% -$53.9K
NOAH
2372
Noah Holdings
NOAH
$591M
$722K ﹤0.01%
24,714
+2,000
+9% +$63.8K
ARNA
2373
DELISTED
Arena Pharmaceuticals Inc
ARNA
$722K ﹤0.01%
15,783
-279
-2% -$15.7K
IBOC icon
2374
International Bancshares
IBOC
$4.48B
$719K ﹤0.01%
18,617
-125
-0.7% -$4.58K
DWAQ
2375
DELISTED
Invesco DWA NASDAQ Momentum ETF
DWAQ
$719K ﹤0.01%
+6,672
New +$784K

Similar funds

Raymond James & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Raymond James & Associates held 3,809 positions worth $71.7B, up 3.4% from $69.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q3 2019 filing shows 183 new, 1,708 increased, 1,572 reduced and 206 closed positions. Its largest new stake was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M. The largest sale was Microchip Technology, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2019 buy was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M.
  • Raymond James & Associates added most to Comcast in Q3 2019, an estimated $203M increase.
  • Raymond James & Associates's biggest Q3 2019 reduction was Microchip Technology, cutting an estimated $155M.
  • Raymond James & Associates fully exited Anadarko Petroleum in Q3 2019, selling an estimated $89.3M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $71.7B portfolio in Q3 2019.
  • Raymond James & Associates opened 183 new positions and closed 206 in Q3 2019.
  • Raymond James & Associates's portfolio value rose 3.4% quarter-over-quarter to $71.7B.

Based on Raymond James & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.